Frontiers in Oncology (Jan 2021)
Case Report: B Lymphocyte Disorders Under COVID-19 Inflammatory Pressure
- Gloria Taliani,
- Gloria Taliani,
- Gloria Taliani,
- Elena Follini,
- Lorenzo Guglielmetti,
- Lorenzo Guglielmetti,
- Lorenzo Guglielmetti,
- Patrizia Bernuzzi,
- Alberto Faggi,
- Patrizia Ferrante,
- Patrizia Ferrante,
- Elisa Fronti,
- Laura Gerna,
- Maria Cristina Leoni,
- Franco Paolillo,
- Giovanna Ratti,
- Alessandro Ruggieri,
- Caterina Valdatta,
- Alessandra Donisi,
- Adriano Zangrandi,
- Lara Pochintesta,
- Carlo Moroni,
- Daria Sacchini,
- Daniele Vallisa,
- Mauro Codeluppi,
- the COVID-Piacenza Group,
- Daniela Aschieri,
- Mario Barbera,
- Carlo Cagnoni,
- Luigi Cavanna,
- Cosimo Franco,
- Chiara Gorrini,
- Andrea Magnacavallo,
- Massimo Nolli,
- Massimo Piepoli,
- Roberta Schiavo,
- Matteo Silva,
- Marco Stabile,
- Angela Rossi,
- Giovanni Vadacca
Affiliations
- Gloria Taliani
- Infectious Diseases Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Gloria Taliani
- Anti-COVID-19 Task Force of the Italian Civil Protection, Rome, Italy
- Gloria Taliani
- Infectious and Tropical Disease Unit, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
- Elena Follini
- Hematology and Bone Marrow Transplant (BMT) Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Lorenzo Guglielmetti
- Infectious Diseases Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Lorenzo Guglielmetti
- Sorbonne Université, INSERM, U1135, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, équipe 13, Paris, France
- Lorenzo Guglielmetti
- APHP, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Paris, France
- Patrizia Bernuzzi
- Hematology and Bone Marrow Transplant (BMT) Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Alberto Faggi
- Infectious Diseases Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Patrizia Ferrante
- Infectious Diseases Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Patrizia Ferrante
- Institute for Cross-Disciplinary Physics and Complex Systems IFISC (UIB-CSIC), Campus Universitat Illes Balears, Palma de Mallorca, Spain
- Elisa Fronti
- Infectious Diseases Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Laura Gerna
- Infectious Diseases Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Maria Cristina Leoni
- Infectious Diseases Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Franco Paolillo
- Infectious Diseases Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Giovanna Ratti
- Infectious Diseases Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Alessandro Ruggieri
- Infectious Diseases Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Caterina Valdatta
- Infectious Diseases Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Alessandra Donisi
- Migration Health Unit, Primary Health Care Department, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Adriano Zangrandi
- Pathology Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Lara Pochintesta
- Hematology and Bone Marrow Transplant (BMT) Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Carlo Moroni
- Hematology and Bone Marrow Transplant (BMT) Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Daria Sacchini
- Infectious Diseases Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Daniele Vallisa
- Hematology and Bone Marrow Transplant (BMT) Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- Mauro Codeluppi
- Infectious Diseases Unit, “Guglielmo da Saliceto” Piacenza Hospital, Piacenza, Italy
- the COVID-Piacenza Group
- Daniela Aschieri
- Mario Barbera
- Carlo Cagnoni
- Luigi Cavanna
- Cosimo Franco
- Chiara Gorrini
- Andrea Magnacavallo
- Massimo Nolli
- Massimo Piepoli
- Roberta Schiavo
- Matteo Silva
- Marco Stabile
- Angela Rossi
- Giovanni Vadacca
- DOI
- https://doi.org/10.3389/fonc.2020.582901
- Journal volume & issue
-
Vol. 10
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infects humans through the angiotensin converting enzyme-2 (ACE-2) receptor expressed on many cells, including lymphocytes. In Covid-19 patients IL-6 is overexpressed, and hyperactivated plasmacytoid lymphocytes are detected in peripheral blood film. We hypothesize that, due to the unpredictable interaction between the new virus and the B cell lineage of infected patients, a cascade of out of control events can ensue, capable of determining unexpected pathologic disorders involving such lineage. Here we report two cases of autoimmune hemolytic anemia (AIHA) and two cases of B-cell hematological malignancies developed or reactivated during acute SARS-CoV-2 infection. The temporal relationship of the events may suggest a potential causal relationship between SARS-CoV-2 infection and the hematopoietic disorders. We suggest that special attention should be paid to COVID-19 patients with underlining B cell lineage disorders.
Keywords
- COVID-19
- B-cell lineage malignancies
- reactivation
- autoimmune hemolytic anemia
- multiple myeloma
- acute lymphoblastic leukemia